Title: Urokinase-type Plasminogen Activator Resulting from Endometrial Carcinogenesis Enhances Tumor Invasion and Correlates with Poor Outcome of Endometrial Carcinoma Patients
Authors: Huang, Chia-Yen
Chang, Ming-Cheng
Huang, Wei-Yun
Huang, Ching-Ting
Tang, Yu-Chien
Huang, Hsien-Da
Kuo, Kuan-Ting
Chen, Chi-An
Cheng, Wen-Fang
生物資訊及系統生物研究所
Institude of Bioinformatics and Systems Biology
Issue Date: 2-Jun-2015
Abstract: The purpose of this study was to identify the dysregulated genes involved in the tumorigenesis and progression of endometrial endometrioid adenocarcinoma (EEC), and their possible mechanisms. Endometrial specimens including normal endometrial tissues, atypical endometrial hyperplasia, and EEC were analyzed. The expression profiles were compared using GeneChip Array. The gene expression levels were determined by real-time RT-PCR in the training and testing sets to correlate the clinico-pathological parameters of EEC. Immunoblotting, in vitro cell migration and invasion assays were performed in human endometrial cancer cell lines and their transfectants. In microarray analysis, seven dysregulated genes were identified. Only the levels of urokinase-type plasminogen activator (uPA) were higher in EEC with deep myometrial invasion, positive lympho-vascular space invasion, lymph node metastasis, and advanced stages. After multivariate analysis, uPA was the only independent poor prognostic factor for disease-free survival in the EEC patients (hazard ratio: 4.65, p - 0.03). uPA may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, Akt and p38 molecules. uPA is a dysregulated gene involved in the tumorigenesis, bio-pathological features and outcomes of EEC. uPA may be a potential molecule and target for the detection and treatment of EEC.
URI: http://dx.doi.org/10.1038/srep10680
http://hdl.handle.net/11536/124778
ISSN: 2045-2322
DOI: 10.1038/srep10680
Journal: SCIENTIFIC REPORTS
Appears in Collections:Articles